January 30 – February 1, 2024 | Boston, MA
As recent advances in degrading molecular glues from the bench to the clinic significantly expand the druggable target space, the 2nd Molecular Glue Drug Development Summit returns with 3 days of jam-packed content to address your burning questions including but not limited to:
- How can AI supplement the forward prediction of molecular glue rational discovery?
- How to leverage structural biology technologies to uncover the properties of ternary complexes?
- How to ensure high bioavailability of orally delivered molecular glues?
- How can we comprehensively expand the glueable E3 Ligase landscape beyond CRBN, VHL and DCAF15?How to fast-track IND-filing & accelerate the progression of novel molecular glue candidates into the clinic?
Bringing together expert Directors, Vice Presidents, Senior Scientists of Medicinal Chemistry, Structural Biology, Drug Discovery, and more, make sure you don’t miss out on joining 80+ pioneers at the 2nd Molecular Glue Drug Discovery Summit to accelerate and de-risk your pipelines and address unmet clinical needs of patients in oncology, CNS and beyond!
